Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Escribano

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
The American Journal of Pathology|February 25, 2003
One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probesKarl Sotlar, Luis Escribano, Olfert Landt, et al.
Leukemia Research|April 12, 2003
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteriaPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Immunology and Allergy Clinics of North America|April 22, 2014
Bone involvement and osteoporosis in mastocytosisMaurizio Rossini, Roberta Zanotti, Ombretta Viapiana, et al.
Cytometry. Part B, Clinical Cytometry|March 3, 2004
Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)Luis Escribano, Beatriz Diaz-Agustin, Antonio López, et al.
International Archives of Allergy and Immunology|June 18, 2002
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of diseaseWolfgang R Sperr, John-Hendrik Jordan, Michael Fiegl, et al.
Clinical and Translational Allergy|March 28, 2022
Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory featuresTiago Azenha Rama, José Mário Morgado, Ana Henriques, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 26, 2017
Systemic mastocytosis with <i>KIT</i> V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcomeIolanda Conde-Fernandes, Rita Sampaio, Filipa Moreno, et al.
Neurobiology of Disease|December 23, 2008
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levelsAna-María Simón, Lucio Schiapparelli, Pablo Salazar-Colocho, et al.
Leukemia & Lymphoma|December 29, 2004
Mastocytosis: pathology, genetics, and current options for therapyPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & ImmunologyMelody C Carter, Dean D Metcalfe, Almudena Matito, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The American Journal of Pathology|February 25, 2003
One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probesKarl Sotlar, Luis Escribano, Olfert Landt, et al.
Leukemia Research|April 12, 2003
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteriaPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Immunology and Allergy Clinics of North America|April 22, 2014
Bone involvement and osteoporosis in mastocytosisMaurizio Rossini, Roberta Zanotti, Ombretta Viapiana, et al.
Cytometry. Part B, Clinical Cytometry|March 3, 2004
Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)Luis Escribano, Beatriz Diaz-Agustin, Antonio López, et al.
International Archives of Allergy and Immunology|June 18, 2002
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of diseaseWolfgang R Sperr, John-Hendrik Jordan, Michael Fiegl, et al.
Clinical and Translational Allergy|March 28, 2022
Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory featuresTiago Azenha Rama, José Mário Morgado, Ana Henriques, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 26, 2017
Systemic mastocytosis with <i>KIT</i> V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcomeIolanda Conde-Fernandes, Rita Sampaio, Filipa Moreno, et al.
Neurobiology of Disease|December 23, 2008
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levelsAna-María Simón, Lucio Schiapparelli, Pablo Salazar-Colocho, et al.
Leukemia & Lymphoma|December 29, 2004
Mastocytosis: pathology, genetics, and current options for therapyPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & ImmunologyMelody C Carter, Dean D Metcalfe, Almudena Matito, et al.
Pageof 7